Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Regen Biopharma Inc (RGBP)

Regen Biopharma Inc (RGBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Regen BioPharma, Inc. Expands Vision for Phase 1 Clinical Trial of HemaXellerate™ GlobeNewswire - Tue Nov 19, 3:05PM CST

RGBP : 0.0575 (-23.33%)
RGBPP : 0.0948 (+51.20%)
Regen BioPharma, Inc. to Present at the Emerging Growth Conference on May 9, 2024 Newswire.ca - Tue May 7, 1:44PM CDT

/CNW/ -- Regen BioPharma, Inc. (OTC PINK: RGBP) (OTC PINK: RGBPP), a biotechnology company advancing a diverse pre-clinical pipeline spanning cell therapies,...

RGBP : 0.0575 (-23.33%)
RGBPP : 0.0948 (+51.20%)
Regen BioPharma, Inc. to Present at the Emerging Growth Conference on March 7, 2024 Newswire.ca - Tue Mar 5, 7:30AM CST

/CNW/ -- Regen BioPharma, Inc. (OTC PINK: RGBP) (OTC PINK: RGBPP), a biotechnology company advancing a diverse pre-clinical pipeline spanning cell therapies,...

RGBP : 0.0575 (-23.33%)
RGBPP : 0.0948 (+51.20%)
Regen BioPharma, Inc. to Present at the Emerging Growth Conference on February 7, 2024 Newswire.ca - Mon Feb 5, 6:00AM CST

/CNW/ -- Regen BioPharma, Inc. (OTC PINK: RGBP) (OTC PINK: RGBPP), a biotechnology company advancing a diverse pre-clinical pipeline spanning cell therapies,...

RGBP : 0.0575 (-23.33%)
RGBPP : 0.0948 (+51.20%)
Regen BioPharma, Inc. Receives First Phase of Confirmatory Study PR Newswire - Tue Oct 10, 2023

/PRNewswire/ -- Regen BioPharma, Inc. (OTC PINK: RGBP) (OTC PINK: RGBPP) has previously discussed initiation of a series of experiments to validate its DuraCAR...

RGBP : 0.0575 (-23.33%)
RGBPP : 0.0948 (+51.20%)
Regen BioPharma Leverages Exosome Technologies to Broaden its Survivin Cancer Immunotherapy Portfolio PR Newswire - Fri Jan 20, 2023

/PRNewswire/ -- Regen BioPharma, Inc. (OTC PINK: RGBP) and (OTC PINK: RGBPP), a biotechnology company advancing a diverse pre-clinical pipeline spanning cell...

RGBP : 0.0575 (-23.33%)
RGBPP : 0.0948 (+51.20%)
Regen BioPharma, Inc. issues Message to the Shareholders from the Chairman And Chief Executive Officer PR Newswire - Mon Dec 19, 2022

/PRNewswire/ -- Regen BioPharma, Inc. (OTC PINK: RGBP) and (OTC PINK: RGBPP) As 2022 comes to a close, I would like to highlight some our many accomplishments...

RGBP : 0.0575 (-23.33%)
RGBPP : 0.0948 (+51.20%)
Regen BioPharma Appoints Two New Scientific Advisory Board Members PR Newswire - Wed Dec 7, 2022

/PRNewswire/ -- Regen BioPharma, Inc. (OTC PINK: RGBP) and (OTC PINK: RGBPP) announced that Dr. Ravinder Reddy, a Professor of Radiology at the University of...

RGBP : 0.0575 (-23.33%)
RGBPP : 0.0948 (+51.20%)
Regen BioPharma, Inc. Progresses Its DuraCAR Therapeutic PR Newswire - Fri Nov 18, 2022

/PRNewswire/ -- Regen BioPharma, Inc. (OTC PINK: RGBP) and (OTC PINK: RGBPP) has previously discussed initiation of a series of experiments to validate its...

RGBP : 0.0575 (-23.33%)
RGBPP : 0.0948 (+51.20%)
Regen BioPharma Developing a Non-Exhaustible CAR-T Cell Therapeutic PR Newswire - Thu Nov 10, 2022

/PRNewswire/ -- Regen BioPharma, Inc. (OTC PINK: RGBP) and (OTC PINK: RGBPP)has recently discussed the use of CAR-T therapies in cancer treatment...

RGBP : 0.0575 (-23.33%)
RGBPP : 0.0948 (+51.20%)

Barchart Exclusives

3 Pharma Stocks to Buy as California Sounds the Alarm on Bird Flu Cases Barchart - Mon Dec 23, 3:37PM CST
The bird flu crisis is creating investment opportunities in the pharmaceutical sector, with Sanofi, GSK, and CSL Limited emerging as top picks. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot